Conde, M. B., Efron, A., Loredo, C., De Souza, G. R. M., Graça, N. P., Cezar, M. C., . . . Chaisson, R. E. (2009). Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: A double-blind, randomised, controlled phase II trial. The Lancet (British edition), 373(9670), 1183-1189. https://doi.org/10.1016/S0140-6736(09)60333-0
Citace podle Chicago (17th ed.)Conde, Marcus B., et al. "Moxifloxacin Versus Ethambutol in the Initial Treatment of Tuberculosis: A Double-blind, Randomised, Controlled Phase II Trial." The Lancet (British Edition) 373, no. 9670 (2009): 1183-1189. https://doi.org/10.1016/S0140-6736(09)60333-0.
Citace podle MLA (9th ed.)Conde, Marcus B., et al. "Moxifloxacin Versus Ethambutol in the Initial Treatment of Tuberculosis: A Double-blind, Randomised, Controlled Phase II Trial." The Lancet (British Edition), vol. 373, no. 9670, 2009, pp. 1183-1189, https://doi.org/10.1016/S0140-6736(09)60333-0.